6077 A meta-analysis of the CRYSTAL and OPUS studies combining cetuximab with chemotherapy (CT) as 1st-line treatment for patients (pts) with metastatic colorectal cancer (mCRC): Results according to KRAS and BRAF mutation status - Concepedia

Concepedia

Publication | Closed Access

6077 A meta-analysis of the CRYSTAL and OPUS studies combining cetuximab with chemotherapy (CT) as 1st-line treatment for patients (pts) with metastatic colorectal cancer (mCRC): Results according to KRAS and BRAF mutation status

42

Citations

0

References

2009

Year

Eric Van Cutsem, P. Rougier, C.-H. Köhne, Christopher Stroh, M. Schlichting, Carsten Bokemeyer

European Journal of Cancer Supplements

MedicineColorectal CancerPathologyMetastatic Colorectal CancerOpus StudiesCancer TreatmentOncologyRadiation OncologyCancer ResearchMolecular OncologyBraf Mutation Status

No additional data available for this publication yet. Check back later!